Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891554-02-001866
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
8
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d50117_10-k.htm 10-K 702309
3 AMENDMENT TO 1997 LONG TERM INCENTIVE PLAN d50117_ex10-24.htm EX-10.24 3149
4 AMENDMENT TO 1999 LONG TERM INCENTIVE PLAN d50117_ex10-25.htm EX-10.25 3149
5 AMENDMENT TO 2000 LONG TERM INCENTIVE PLAN d50117_ex10-26.htm EX-10.26 3117
6 CREDIT AGREEMENT d50117_ex10-28.htm EX-10.28 282350
7 FIRST AMENDATORY AGREEMENT d50117_ex10-29.htm EX-10.29 18006
8 SECOND AMENDATORY AGREEMENT d50117_ex10-30.htm EX-10.30 64864
9 INDEPENDENT AUDITORS' CONSENT d50117_ex23.htm EX-23 2614
  Complete submission text file 0000891554-02-001866.txt   1081954
Mailing Address 521 WEST 57TH STREET NEW YORK NY 10019
Business Address 521 WEST 57TH STREET NEW YORK NY 10019 2126980300
IMPATH INC (Filer) CIK: 0001003114 (see all company filings)

EIN.: 133459685 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27750 | Film No.: 02598094
SIC: 8071 Services-Medical Laboratories